Holen Sie sich die Stockscreener-App
48.25
12.02%
-6.59
Handel nachbörslich:
47.75
-0.50
-1.04%
Schlusskurs vom Vortag:
$54.84
Offen:
$47
24-Stunden-Volumen:
4.49M
Relative Volume:
3.78
Marktkapitalisierung:
$1.39B
Einnahmen:
$911.98M
Nettoeinkommen (Verlust:
$145.42M
KGV:
9.7196
EPS:
4.9642
Netto-Cashflow:
$78.48M
1W Leistung:
-12.45%
1M Leistung:
-12.26%
6M Leistung:
-41.74%
1J Leistung:
-69.60%
1-Tages-Spanne:
$44.41
$48.38
1-Wochen-Bereich:
$44.41
$57.91
52-Wochen-Spanne:
$44.41
$163.35
Inspire Medical Systems Inc Stock (INSP) Company Profile
Firmenname
Inspire Medical Systems Inc
Sektor
Branche
Telefon
763-957-5037
Adresse
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
48.25 | 1.58B | 911.98M | 145.42M | 78.48M | 4.9642 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2026-02-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2026-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2026-01-27 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2026-01-22 | Herabstufung | Truist | Buy → Hold |
| 2025-12-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Hochstufung | Truist | Hold → Buy |
| 2025-11-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Hochstufung | Stifel | Hold → Buy |
| 2025-11-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2025-09-02 | Eingeleitet | Evercore ISI | Outperform |
| 2025-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Herabstufung | Truist | Buy → Hold |
| 2024-11-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-04-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-03-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2024-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-14 | Eingeleitet | Mizuho | Buy |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-12-13 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-11-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-11-03 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Eingeleitet | JP Morgan | Overweight |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-15 | Eingeleitet | Goldman | Buy |
| 2020-06-18 | Bestätigt | Piper Sandler | Overweight |
| 2020-05-18 | Eingeleitet | Lake Street | Buy |
| 2020-04-28 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-28 | Eingeleitet | Oppenheimer | Underperform |
| 2020-01-27 | Eingeleitet | Oppenheimer | Underperform |
| 2019-11-06 | Hochstufung | Berenberg | Sell → Hold |
| 2019-02-05 | Eingeleitet | Dougherty & Company | Buy |
| 2018-11-28 | Eingeleitet | Berenberg | Sell |
| 2018-10-29 | Eingeleitet | Leerink Partners | Outperform |
| 2018-05-29 | Eingeleitet | Guggenheim | Buy |
| 2018-05-29 | Eingeleitet | Stifel | Buy |
| 2018-05-29 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Inspire Medical Systems Inc Aktie (INSP) Neueste Nachrichten
Inspire: Why I'm Still Rating The Stock A 'Sell' After The Earnings Dip (NYSE:INSP) - Seeking Alpha
Inspire Medical Shareholders Approve Board Declassification and Governance Changes - TipRanks
Investors back new equity plan and board changes at Inspire Medical (NYSE: INSP) - Stock Titan
Inspire Medical Q1 Earnings Beat Estimates, 2026 View Cut, Stock Down - Zacks Investment Research
Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why - TradingView
Inspire Medical Systems Faces Limited Visibility, RBC Says - marketscreener.com
Stifel cuts Inspire Medical stock price target on weak guidance By Investing.com - Investing.com Canada
Inspire Medical Systems Q1 2026 earnings preview - MSN
Piper Sandler Downgrades Inspire Medical Systems to Neutral From Overweight, $85 Price Target - Moomoo
Inspire Medical Systems stock hits 52-week low at $45.00 - Investing.com
Inspire Medical Systems Sees 2026 EPS 7c-EPS 62c >INSP - Moomoo
Inspire Medical Systems, Inc. Reports Q1 2026 Financial Results and Forward-Looking Statements - Minichart
Stock Market Today: Dow, S&P 500, Nasdaq Futures Rise As Traders Monitor US-Iran Ceasefire— Duolingo, Pinterest, AMD In Focus (UPDATED) - Benzinga
Truist Securities Adjusts Price Target on Inspire Medical Systems to $50 From $64, Maintains Hold Rating - marketscreener.com
Inspire Medical Systems, Inc. (NYSE:INSP) Q1 2026 Earnings Call Transcript - Insider Monkey
BofA cuts Inspire Medical stock rating on reimbursement concerns By Investing.com - Investing.com Canada
Mizuho cuts Inspire Medical Systems stock price target on guidance reduction - Investing.com Canada
Inspire Medical Systems 1Q Adj EPS 10c >INSP - Moomoo
Inspire Medical Systems (INSP) Q1 earnings and revenues top estimates - MSN
INSP Q1 Deep Dive: Coding Headwinds and WISER Program Drive Down Full-Year Outlook - TradingView
Inspire Medical Q1 2026 slides: strong earnings beat masks growth slowdown - Investing.com Canada
Inspire Medical Systems Earnings Preview: Revenue Expected Flat - IndexBox
Inspire Medical Systems, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
INSP: 2026 revenue guidance cut to $825–$875M due to reimbursement and WISeR headwinds - TradingView
Earnings call transcript: Inspire Medical beats Q1 2026 EPS forecasts By Investing.com - Investing.com South Africa
Inspire Medical Systems Sees 2026 Adj EPS 75c-Adj EPS $1.25 >INSP - Moomoo
Inspire (INSP) Q1 2026 Earnings Call Transcript - The Globe and Mail
Director at Inspire Medical (INSP) granted 3,562 RSUs - Stock Titan
Inspire Medical Systems (INSP) grants 3,562 RSUs to board director - Stock Titan
Inspire Medical (INSP) director receives 3,562-share RSU award - Stock Titan
Director at Inspire Medical (INSP) receives 3,562 RSU equity award - Stock Titan
Director Cynthia Burks receives 3,562 RSUs at Inspire Medical (INSP) - Stock Titan
Director Shelley G. Broader granted 3,562 RSUs at Inspire Medical (INSP) - Stock Titan
Full Transcript: Inspire Medical Systems Q1 2026 Earnings Call - Benzinga
Inspire Medical Systems (INSP) director receives 3,562 RSUs in equity grant - Stock Titan
Inspire Medical Systems (INSP) director gets 3,562 RSUs and 50-share tax withholding - Stock Titan
Earnings call transcript: Inspire Medical beats Q1 2026 EPS forecasts - Investing.com
Inspire (INSP) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Inspire Medical Systems (INSP) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
Inspire Medical Cuts 2026 Outlook Amid Reimbursement Headwinds - TipRanks
Inspire Medical Systems Q1 Adjusted Earnings Flat, Revenue Rises; Lowers Full-Year Guidance - marketscreener.com
(INSP) Inspire Medical Systems Now Expects Full Year 2026 Revenue Range $825M$875M, vs. FactSet Est of $961.9M - marketscreener.com
Inspire Medical : First Quarter 2026 Earnings Presentation - marketscreener.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Q1 2026 Inspire Medical Systems Inc Earnings Call Transcript - GuruFocus
Inspire Medical Systems (NYSE:INSP) Q1 Earnings Beat on Profit But Revenue Miss Sends Stock Plummeting - ChartMill
Inspire Medical slashes 2026 guidance amid reimbursement uncertainty - MassDevice
Inspire: Q1 Earnings Snapshot - marketscreener.com
Earnings Flash (INSP) Inspire Medical Systems, Inc. Posts Q1 Adjusted EPS $0.10 per Share - marketscreener.com
Inspire Medical Systems’s (NYSE:INSP) Q1 CY2026 Sales Top Estimates But Stock Drops 18.8% - Yahoo Finance
[10-Q] Inspire Medical Systems, Inc. Quarterly Earnings Report - Stock Titan
Finanzdaten der Inspire Medical Systems Inc-Aktie (INSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):